Lung cancer Board decisions

The Board denied an initial rating in excess of 10 percent for tinnitus and a compensable rating for bilateral hearing loss. The claims for service connection for headache disorder, sinusitis, obstructive sleep apnea, COPD, colon cancer, and lung cancer were remanded for further development.

The Board remands the Veteran's claim for an increased rating for lung cancer residuals due to inadequate examination and need for a more comprehensive evaluation of all respiratory conditions.

The Board denied service connection for coronary artery disease, diabetes mellitus, type II, and lung cancer as the evidence did not support a finding of in-service exposure to herbicides or that these conditions were related to service. The cause of death was also denied.

The Board granted service connection for left posterior cervical sebaceous cyst excision scar residuals and remanded the claims for other disabilities related to herbicide exposure.

The Board denied service connection for skin cancer, to include melanoma, and remanded the claims for squamous cell cancer of the left tonsil and a compensable disability rating for lung cancer.

The Board denied the veteran's claim for service connection for lung cancer, to include as due to water contamination at Camp Lejeune, and remanded the issue of compensation under 38 U.S.C. § 1151 for stage 2 lung cancer.

The Board granted readjudication of the appeal for entitlement to service connection for lung cancer based on new and relevant evidence, but remanded the claim for further development.

The Board granted service connection for colorectal cancer, lung cancer, spinal cancer, neuropathy in the thoracic paraspinal region, a bilateral circulatory disability of the lower extremities, a bilateral skin disability of the lower extremities, residuals of a stroke as secondary to hypertension, and cause of death. Some issues were remanded.

The Board denied the veteran's claim for service connection for lung cancer, to include as due to water contamination at Camp Lejeune, and remanded the issue of compensation under 38 U.S.C. § 1151 for stage 2 lung cancer.

The appeals for service connection for chronic kidney disease, left kidney radical nephrectomy, status post clear cell carcinoma, and lung cancer have been withdrawn by the Veteran's attorney.

The appeal for service connection for throat cancer was granted, while other issues were remanded. The claim for asthma and related conditions was reopened but not decided.

The claims for service connection for lung cancer and brain cancer, as well as the claim for a total disability rating based on individual unemployability (TDIU), are remanded to ensure compliance with Board remand instructions and obtain an addendum opinion regarding potential toxic exposure.

The Board granted service connection for lung cancer, on a direct facts-found basis, due to the Veteran's exposure to toxic substances during his active service.

The Board granted service connection for lung cancer under the PACT Act, but remanded the claim for obstructive sleep apnea.

The Board remands the claim for service connection of the Veteran's cause of death to obtain an opinion on whether lung cancer is related to in-service exposure and to provide notice of the Appellant's right to a hearing.

The appeal of entitlement to a compensable rating for lung cancer was withdrawn by the Veteran's authorized representative.

The Board remands the issue of entitlement to service connection for lung cancer, claimed as respiratory cancer, due to in-service herbicide exposure for further development.

The Board granted service connection for lung cancer and pancreatic cancer on a direct basis, finding that the Veteran's exposure to toxins during his service in Iraq likely caused these conditions.

The Board denied an earlier effective date for the award of service connection for lung cancer, metastatic bone cancer, and lymph node cancer.

The appeal for service connection for lung cancer was dismissed due to the Veteran's death during the pendency of the appeal.